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Sindbis virus (SINV), a mosquito-borne virus that 
causes rash and arthritis, has been causing outbreaks in 
humans every seventh year in northern Europe. To gain a 
better understanding of SINV epidemiology in Finland, we 
searched for SINV antibodies in 621 resident grouse, whose 
population declines have coincided with human SINV out-
breaks, and in 836 migratory birds. We used hemagglutina-
tion-inhibition and neutralization tests for the bird samples 
and enzyme immunoassays and hemagglutination-inhibition 
for the human samples. SINV antibodies were ﬁ  rst found in 
3 birds (red-backed shrike, robin, song thrush) during their 
spring migration to northern Europe. Of the grouse, 27.4% 
were seropositive in 2003 (1 year after a human outbreak), 
but only 1.4% were seropositive in 2004. Among 2,529 per-
sons, the age-standardized seroprevalence (1999–2003) 
was 5.2%; seroprevalence and incidence (1995–2003) were 
highest in North Karelia (eastern Finland). Grouse may con-
tribute to the epidemiology of SINV in humans.
S
indbis virus (SINV) was ﬁ  rst recognized and isolated in 
1952 from a pool of Culex pipiens and Cx. univittatus 
mosquitoes collected from a village in the Nile River delta 
in Egypt, after which the virus was named (1). SINV, a 
member of the western equine encephalomyelitis complex 
of the genus Alphavirus in the family Togaviridae, is an en-
veloped virus with a genome of single-stranded, positive-
polarity, 11.7-kb RNA (2). SINV is present throughout the 
Old World but has never been found in the New World 
(the Americas). SINV seropositivity in humans has been 
reported in various areas, and antibodies to SINV have also 
been found from various bird (3–5) and mammal (6,7) spe-
cies. The virus has been isolated from several mosquito 
species, frogs (8), reed warblers (9), bats (10), ticks (11), 
and humans (12–14).
Despite the wide distribution of SINV, symptomatic 
infections in humans have been reported in only a few 
geographically restricted areas, such as northern Europe, 
and occasionally in South Africa (12), Australia (15–18), 
and China (13). In the early 1980s in Finland, serologic 
evidence associated SINV with rash and arthritis, known 
as Pogosta disease (19). In 2002, SINV was conﬁ  rmed as 
the causative agent of Pogosta disease by isolating the virus 
from acutely ill patients (14). The typical clinical picture 
of acute Pogosta disease consists of arthritis, itching rash, 
fatigue, mild fever, headache, and muscle pain (20). Since 
1974 in Finland, the disease has occurred as epidemics of 
hundreds or even thousands of patients every seventh year 
(1974, 1981, 1988, 1995, 2002). Similar disease is also 
found in Sweden (Ockelbo disease) and Russian Karelia 
(Karelian fever).
Most clinical cases in Finland are reported during Au-
gust and September; the ornithophilic late summer mos-
quito species, Culex and Culiseta, are presumed to be the 
primary vectors (21). Grouse (Tetraonidae) (4) and passer-
ines (especially thrushes, Turdidae) (5,22) have been sug-
gested as amplifying hosts for SINV in northern Europe. 
Grouse are of special interest because they have previously 
had a 6–7 year population cycle with population declines 
coinciding with SINV outbreaks (4,23,24). Migratory birds 
may also play a role in distributing SINV over long distanc-
es, as they do with West Nile and avian inﬂ  uenza viruses. 
Supporting information is provided by the fact that SINV is 
disseminated over vast geographic areas of Australia with 
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isolates from widely separated locations sharing identical 
nucleotide sequences (25). Studies on antigenic relatedness 
of alphaviruses have also suggested that progenitor alpha-
viruses are spread over long distances by birds (26). Fur-
thermore, phylogenetic studies have indicated that South 
African and northern European SINV strains are closely 
related (14,27). Therefore, the hypothesis is that migratory 
birds have carried the virus to northern Europe.
A previous human epidemiologic study on SINV from 
Finland (4) reported an annual incidence of 2.7/100,000 dur-
ing 1989–1996 and a seroprevalence of 0.6% in women of 
reproductive age during 1992. In addition, SINV antibodies 
were found in a small number of game birds and mammals in 
Ilomantsi, eastern Finland, during 1981–1983 (4). We stud-
ied the human epidemiology of SINV during an additional 
7-year period in Finland and the seroprevalence of SINV in 
resident grouse. Furthermore, we looked for SINV antibod-
ies in migratory birds arriving in northern Europe. Our aim 
was to elucidate factors contributing to the epidemiologic 
pattern of SINV infections in humans in Finland.
Methods
National Surveillance for SINV and Testing of Human 
Serum Samples
We used data reported from January 1995 to Decem-
ber 2003 in our analysis of incidence of SINV in the Finn-
ish population. Since 1995, all Finnish clinical microbiol-
ogy laboratories have reported laboratory-conﬁ  rmed (by 
antibody detection) diagnoses of SINV infection to the Na-
tional Infectious Disease Registry, maintained by the Na-
tional Public Health Institute in Helsinki. Most laboratory 
reporting is done electronically and includes date of speci-
men collection and patient’s date of birth, sex, and place 
of treatment. Multiple reports for the same person received 
within a 12-month period are combined as a single case. 
For our analysis of the seroprevalence of SINV in the 
Finnish population, we used all samples from October 6, 
1999, to May 8, 2003, that were tested for SINV antibodies 
at Helsinki University Central Hospital Laboratory. This 
laboratory performs >70% of the SINV antibody testing in 
Finland; other testing is performed by the Department of 
Virology at the University of Turku. We included only the 
most recent sample from patients with multiple samples; 
we excluded samples from those who had acute SINV in-
fection (immunoglobulin [Ig] M positive).
Testing of Resident Grouse 
Blood samples from grouse were collected by hunters 
from September 10 through October 31, 2003, and the same 
dates in 2004. The blood was absorbed into small slips of 
ﬁ  lter paper, dried, and stored individually at –20°C. The 
age and sex of the grouse were determined by hunters.
Testing of Migratory Birds
In 2004, blood samples were collected from migratory 
birds in 2 bird observatories during their spring migration: 
on Jurmo Island (59°50′N, 21°36′E) on May 18 and 19 and 
in Tauvo (64°49′N, 24°37′E) May 24–27. In 2005, blood 
samples were also collected in 2 different bird observatories 
during the spring migration: on Lågskär Island (59°50′N, 
19°55′E) May 22–25 and in Tauvo May 29–31. In addi-
tion, migratory bird samples were collected in Kokkola 
archipelago (63°52′N, 23°4′E) on July 30, 2005 (Figure 1, 
panel A). Birds were captured with mist nets and identiﬁ  ed 
by certiﬁ  ed bird ringers. Blood samples were obtained by 
absorbing blood from the veins of wings or feet into ﬁ  lter 
paper slips and then dried. When possible, samples from 
native birds were also collected into small glass capillary 
tubes. Samples from migratory birds were collected with 
the permission of the Animal Experiment Committee of 
the University of Helsinki (permission no. HY75-04). We 
used the English and scientiﬁ  c names of birds according to 
Cramp et al. (28).
Serologic Testing 
The human serum samples were examined for SINV 
IgM and IgG antibodies by enzyme immunoassays (EIA) 
and for SINV total antibodies by hemagglutination-in-
hibition (HI) testing. The protocols for EIA (29) and HI 
(29,30), as well as the diagnostic criteria for acute infec-
tion and previous immunity (29), have been described. In 
the incidence analysis, ≈25% of the seropositive diagnoses 
were made by using EIA at the University of Turku, where 
HI testing was not used.
The bird samples were screened for antibodies by 
HI testing. Approximately 1 cm2 of each blood-saturated 
dry ﬁ  lter paper slip was cut into small pieces, and 1 mL 
of Dulbecco phosphate-buffered saline plus 0.2% bovine 
serum albumin was added to elute the blood. The resulting 
dilution corresponded to an ≈1:10 serum dilution (19), as 
veriﬁ  ed by parallel titrations with blood (on ﬁ  lter paper) 
and serum samples from a seropositive person, which were 
used as controls. A liquid dilution (250 μL) was used for 
HI analysis. 
HI testing was performed with 2-fold dilutions (1:20–
1:640). Only titers >40 were considered positive. Perfor-
mance of the HI technique on bird samples was conﬁ  rmed 
by comparison with a set of HI-positive and HI-negative 
human samples and with neutralization tests (NTs) in which 
endpoint neutralizing antibody titers inhibiting cytopathic 
effect on Vero E6 cells were determined ≈65 h after infec-
tion. All samples in the subset with an HI titer >40 (n = 7) 
showed NT titers >20, and all samples in the subset with an 
HI titer <20 (n = 8) showed NT titers <20. In addition, all 
samples with borderline HI results were determined by NT 
to be negative.
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Results
Human Population
A total of 2,529 human specimens were included in 
our analysis. When the data were standardized according to 
the age distribution of the Finnish population, the estimated 
seroprevalence was 5.2% (Figure 2). Geographically, the 
seroprevalence was high in eastern Finland, especially in 
North Karelia and Kainuu, but also in central Ostrobothnia 
in western Finland (Figure 1, panel B). Seroprevalence was 
signiﬁ  cantly higher for men (6.0%; mean age of all men 
studied 41.8 years) than for women (4.1%; mean age of all 
women studied 44.1 years) (χ2 4,721, p<0.030). Seropreva-
lence increased with age, reaching 15.4% among persons 
60–69 years of age (Figure 2).
The incidence of SINV during epidemic years was 
25.6/100,000/year in 1995 and 11.5/100,000/year in 2002 
(Figure 1, panel B); the average annualized incidence in 
nonepidemic years (1996–2001 and 2003) was 2.4/100,000. 
The rates for women and men were 8.7 and 6.6/100,000, 
respectively. The average annualized incidence was high-
est (13.5/100,000) among persons 50–59 years of age 
(Figure 2). Rates were higher for persons in the eastern parts 
than in the central part of the country and were highest in 
North Karelia (25.7/100,000; Figure 1, panel C); incidence 
peaked in North Karelia and in southern Ostrobothnia dur-
ing the 1995 and 2002 outbreaks (Figure 3). However, a 
year after the outbreak in 2003, the rates were twice as high 
in southern Ostrobothnia than in North Karelia (Figure 3).
Resident Grouse
A total of 340 blood samples were collected from res-
ident grouse in 2003, and 281 samples were collected in 
2004 (Table 1; Figure 1, panel D). In 2003, a year after a 
human outbreak, the total prevalence of SINV HI antibodies 
in the grouse was 27.4%; in 2004, it declined signiﬁ  cantly 
to 1.4% (Table 1; χ2 76.8, p<0.001). In 2003, the prevalence 
was high in North Karelia (44%), western Finland (south-
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Figure 1. A) Map of Finland with the hospital district divisions. Migratory bird samples were collected from Lågskär, Tauvo, Jurmo, and 
Kokkola. B) Mean seroprevalence (1999–2003) of Sindbis virus (SINV) infection in human population (according to place of treatment) in 
the hospital districts of Finland. N/A, not available. C) Average annualized incidence (1995–2003) of SINV infection in human population 
(according to place of treatment) in the hospital districts of Finland. D) Prevalence of SINV hemagluttination-inhibition antibodies in 
resident grouse in Finland. The left bars represent the year 2003 and right bars 2004. The bars represent the total number of samples 
available; the black areas, the number of seropositive samples. *In 2003 in East Savo, the only sample collected was seropositive. 
Figure 2. Mean seroprevalence (1999–2003) and average 
annualized incidence (1995–2003) of Sindbis virus infection in the 
human population, Finland, according to age groups. *Standardized 
according to the age distribution of the Finnish population in the 
respective period.INTERNATIONAL POLAR YEAR  RESEARCH
ern Ostrobothnia, Vaasa, and central Ostrobothnia) (44%), 
and Central Finland (41%), but pronounced also in Lap-
land in northern Finland (18%) (Figure 1, panel D). Also in 
2003, 27.2% of the male grouse and 28.6% of the female 
grouse were seropositive; in 2004, 2.2% of the males and 
1.3% of the females were seropositive (sex was unknown 
for 132/621 of the grouse). In 2003, 32.0% of the juve-
niles (born the same year) and 23.3% of the adults were 
seropositive; in 2004, none of the juveniles and 2.9% of 
the adults were seropositive (age was unknown for 96/621). 
The distribution of antibody titers in the positive samples 
was as follows: 40–120 (32.0%), 160–480 (42.3%), and 
640–>1,280 (25.8%).
Migratory Birds
A total of 836 blood samples were collected from mi-
gratory birds, of which 806 were collected during spring 
migration in May 2004 and May 2005. SINV HI antibod-
ies were detected in 3 birds during spring migration: a robin 
(Erithacus rubecula) and a song thrush (Turdus philomelos) 
from Tauvo in 2004, and a red-backed shrike (Lanius col-
lurio) from Lågskär in 2005 (Figure 1, panel A; Table 2). 
HI antibody titers were 240, 120, and 40, respectively. The 
song thrush was born the previous year; the age of the other 
2 positive birds was unknown. SINV RNA could not be de-
tected with reverse transcription–PCR (20) from the sero-
positive ﬁ  lter paper slip solutions. Virus isolation (14) from 
the available whole blood samples (kept at –70°C) from the 
seropositive robin and song thrush was not successful.
Discussion
Our ﬁ  ndings show that SINV-seropositive migratory 
birds arrive in northern Europe during spring migration. 
Furthermore, after the 2002 outbreak in humans, SINV 
seroprevalence in grouse decreased markedly between the 
next 2 consecutive hunting seasons (2003 and 2004). These 
ﬁ  ndings suggest that grouse may be involved in the epide-
miology of SINV in humans.
The HI and EIA tests used in this study cross-react 
only poorly between alphaviruses in different antigenic 
complexes but may cross-react with other alphaviruses 
within the same antigenic complex. However, no viruses in 
the western equine encephalomyelitis complex other than 
SINV are known to circulate in northern Europe. Serop-
revalence of SINV in the human population was analyzed 
for persons with suspected Pogosta disease; although this 
sample is not random and was recorded by the place of 
treatment (not residence), it does provide good representa-
tion of different geographic areas.
Although the incidence of SINV infection was higher 
in women than in men, the seroprevalence was higher in 
men. This unexpected ﬁ  nding might be explained by the 
possibility that infected men are more frequently asymp-
tomatic than women, but more investigations are needed. 
The high seroprevalence but low incidence in Kainuu could 
be the result of considerable underdiagnosis.
Before 1965, no Finnish persons were found to be 
SINV seropositive (31); however, from 1981 to 1995, se-
roprevalence of SINV in the Finnish population rose con-
siderably. In 1992, seroprevalence in pregnant women was 
0.6% (4); in our study, seroprevalence in women 20–39 
years of age was 2.3%, which further suggests a continuous 
increase in the seroprevalence of SINV in Finland. These 
data suggest that SINV may have been newly introduced to 
northern Europe during the 1960s to 1970s. As with West 
Nile virus, a candidate vehicle for the distribution of SINV 
is infected migratory birds.
Similar to the incidence we found, the incidence of 
SINV during 1980–1996 was highest in the provinces of 
North Karelia and Central Finland (4). In 2003, however, 
the incidence was highest in southern Ostrobothnia, possi-
bly reﬂ  ecting the high immunity to SINV in North Karelia 
after the 2002 outbreak.
In terms of age, 1 study found SINV seroprevalence 
in 1,850 hospital patients in Finland to be 19% in those 
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Figure 3. Average annualized incidence of Sindbis virus infection in 
human population, Finland, 1995–2003.
Table 1. Resident birds and Sindbis virus, Finland, 2003 and 2004 
2003 2004 Common name  Taxonomic name 
Samples, no. Seropositive, % Samples, no. Seropositive, %
Capercaillie Tetrao urogallus 67 31.3 41 2.4
Black grouse Tetrao tetrix 144 31.3 84 1.2
Hazel grouse Bonasa bonasia 49 22.4 58 3.4
Willow grouse Lagopus lagopus 80 20.0 98 0
Total 340 27.4 281 1.4Sindbis Infection in Birds and Humans, Finland
patients <10 years of age (32). Our results are in contradic-
tion to this because only 1.4% of persons <10 years of age 
were seropositive, and seroprevalence increased gradually 
by age, which we consider a logical ﬁ  nding. In those 60–69 
years of age, almost one sixth of the population had im-
munity to SINV. Considering the high infection rate and 
that the infection may cause prolonged joint symptoms 
(20,33–35), even objectively observed by a physician (36), 
the disease is a potential public health concern.
In 1982 in Sweden, most of the 65 serologically di-
agnosed cases occurred in August. Incidence was highest 
for men 30–39 years of age and women 50–59 years of 
age, and prevalence was highest in central Sweden (37). 
Similar temporal and geographic ﬁ  ndings were reported for 
1981–1987; seroprevalence was 2.5% (38).
The last human outbreak in Finland occurred in 2002; 
≈600 cases were serologically diagnosed. The next year, 
the seroprevalence of SINV in grouse was high. One third 
of the juvenile grouse were seropositive in 2003, which in-
dicates active transmission of the virus to the grouse popu-
lation that year. A large proportion of these grouse showed 
markedly high antibody titers. In 2004, the prevalence 
dropped dramatically; only a few adult grouse were sero-
positive. These data indicate that grouse become exposed 
to SINV and that the virus could have an endemic cycle 
involving grouse. However, other susceptible animals not 
screened in this study could be involved. Detection of high 
antibody titers in 2003 implies that the birds have almost 
certainly been infected and had marked viremia. In addi-
tion, the serologic methods that were used in this study (HI 
and NT) are stringent and can detect only relatively potent 
antibody responses; the true seroprevalence of the birds 
may be higher than that reported here.
Until the late 1980s, ﬂ  uctuation in the grouse popu-
lation densities in Finland was pronounced and regular, 
peaking every 6–7 years (23,24). During the 1970s and 
the 1980s, the human outbreaks and declines in the grouse 
population seemed to coincide (4). More recently, ﬂ  uctua-
tion in the grouse population has been less regular with less 
variation in population density (39). Whether the ﬂ  uctua-
tion of the grouse populations could be a cause or a con-
sequence of the phenomenon behind the 7-year cycle of 
human outbreaks and whether SINV can be pathogenic to 
grouse remain unclear. Notably, in 2003, SINV antibodies 
were detected in various parts of the country, not only in 
areas where human infection was endemic.
During 1983–1985, Francy et al. (21) isolated 14 SINV 
strains from ≈60,000 female mosquitoes in Sweden. Most 
were isolated from Cx. pipiens, Cx. torrentium, and Culiseta 
morsitans, and seropositive birds were detected during a 
similar period, which suggests that these species may be im-
portant enzootic vectors in a bird–mosquito cycle. In 1983, 
neutralizing antibodies were not found in the few hundred 
migratory birds that arrived on the Swedish coast; in the 
same year, antibody prevalence in nesting birds (residents 
and migrants) was 3.4% in July and 10% in August (21). In 
the United Kingdom, SINV antibodies have also been dem-
onstrated in resident and migrant birds and in poultry (3).
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Table 2. Migratory birds and Sindbis virus, Finland, 2004 and 2005*  
No. samples (no. positive) 
2004 2005
Common name  Taxonomic name  Jurmo Tauvo Lågskär Tauvo Kokkola Total 
Willow warbler Phylloscopus trochilus 29 105 159 155 3 451
Garden warbler Sylvia borin 1 1 46 2 3 53
Spotted flycatcher Muscicapa striata 7 1 36 3 47
Pied flycatcher Ficedula hypoleuca 71 9 1 3 7 4 6
Redstart Phoenicurus phoenicurus 81 6 1 0 6 4 0
Whitethroat Sylvia communis 13 4 3 5
Bluethroat Luscinia svecica 13 0 1 3 2
Lesser whitethroat Sylvia curruca 42 4 2 8
Sedge warbler Acrocephalus schoenobaenus 35 1 1 1 9
Red-backed shrike Lanius collurio 18 ( 1 ) 5 1 4
Robin Erithacus rubecula 22  ( 1 ) 5 2 1 1
Song thrush Turdus philomelos 11 (1) 11
Blackcap Sylvia atricapilla 46 1 0
Redpoll Carduelis flammea 31 2 6
Other (<5 individuals/species)†  5 5 19 4 33
Total 70 196 362 178 30 836
*Sampling was conducted during 2004 in Jurmo and Tauvo and during 2005 in Lågskär Island, Tauvo, and Kokkola. One of the birds sampled was not a 
migratory bird (willow tit), and 2 birds were not passerines (cuckoo and wryneck). Sindbis virus hemagluttination-inhibition antibodies were detected in 3 
(a red-backed shrike, a robin, and a song thrush) of 836 samples. 
†<5 birds were available from the following species: chaffinch (Fringilla coelebs) 4 samples, wood warbler (Phylloscopus sibilatrix) 4, icterine warbler 
(Hippolais icterina) 4, reed bunting (Emberiza schoeniclus) 3, siskin (Carduelis spinus) 3, red-breasted flycatcher (Ficedula parva) 2, trush nightingale 
(Luscinia luscinia) 2, chiffchaff (Phylloscopus collybita) 2, willow tit (Parus montanus) 1, wryneck (Jynx torquilla) 1, cuckoo (Cuculus canorus) 1, tree pipit 
(Anthus trivialis) 1, blackbird (Turdus merula) 1, grasshopper warbler (Locustella naevia) 1, rustic bunting (Emberiza rustica) 1, scarlet rosefinch 
(Carpodacus erythrinus) 1, and fieldfare (Turdus pilaris) 1. INTERNATIONAL POLAR YEAR  RESEARCH
SINV-antibody prevalence in passerine birds sampled 
in Sweden between June and August during the 1990s (i.e., 
not during spring migration)—ﬁ  eldfare (43.3%), redwing 
(37.0%), and song thrush (22.2%)—was markedly higher 
than the average (7.7%) of all species studied (5). The prev-
alence was signiﬁ  cantly higher for birds sampled after the 
hatching year (13.9%) than for birds sampled during the 
hatching year (2.4%).
Of the seropositive migratory birds reported here, 
robin and song thrush mainly spend the winter in western 
Europe (some individuals migrate to northwestern Africa) 
(28), and red-backed shrike spend the winter in eastern 
tropical and southern Africa (28). Altogether, 806 of the 
836 samples were collected during spring migration in bird 
observatories, which is usually where the birds ﬁ  rst land 
when they arrive in the country from the sea; the other 30 
were collected during midsummer. However, virus infec-
tion during the previous year in northern Europe cannot be 
excluded. Detection of viable SINV in the migrating birds 
would be the ultimate proof for their involvement in dis-
tributing SINV, but that remains to be shown.  Extended 
longitudinal studies are needed to determine whether resi-
dent reservoir species are able to sustain SINV cycles en-
demically in northern Europe or whether the virus must be 
repeatedly introduced there by migratory birds from the 
southern hemisphere. Although the similarity of mosquito 
isolates of SINV from Sweden and Russia in 1980s and 
from Finnish patients in 2002 (14) favors the endemic cy-
cle, larger analyses of SINV strains from Africa and north-
ern Europe (40) suggest a continuous importation of South 
African strains to northern Europe or vice versa.
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